Last update 01 Nov 2024
Growth Hormone Deficiency With Pituitary Anomalies
Last update 01 Nov 2024
Basic Info
Synonyms CPHD5, GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES, Growth Hormone Deficiency With Pituitary Anomalies + [3] |
Introduction- |
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Confirmatory Validation of Oral Macimorelin as a Growth Hormone (GH) Stimulation Test (ST) for the Diagnosis of Adult Growth Hormone Deficiency (AGHD) in Comparison With the Insulin Tolerance Test (ITT)
100 Clinical Results associated with Growth Hormone Deficiency With Pituitary Anomalies
Login to view more data
100 Translational Medicine associated with Growth Hormone Deficiency With Pituitary Anomalies
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free